Bettina Werle

Bettina Werle

Company: Tollys

Job title: Chief Scientific Officer

Seminars:

Speaker Q&A 10:40 am

Read more

day: Day Two

TL-532, the First Rationally Designed TLR3 Agonist Creates Long-Lasting Tumor Specific Immunity In Vivo 10:15 am

TL-532, a double stranded RNA of 70 base pairs has been designed to obtain optimal dual action of immune cell stimulation and cancer cell apoptosis In vitro TLR3 specificity and TLR3 specific cell death by apoptosis has been demonstrated in multiple cancer cell lines. Comparing its activity on normal versus cancer cells, TL-532 demonstrates an…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.